Skip to main content
Top
Published in: BMC Pregnancy and Childbirth 1/2016

Open Access 01-12-2016 | Research article

The use of anti stretch marks’ products by women in pregnancy: a descriptive, cross-sectional survey

Authors: Miriam Brennan, Mike Clarke, Declan Devane

Published in: BMC Pregnancy and Childbirth | Issue 1/2016

Login to get access

Abstract

Background

Stretch marks (Striae gravidarum) are a cutaneous change occurring commonly during pregnancy. A variety of products are available and promoted as ways to prevent or reduce their development, but it is not clear what products are used most commonly. The objective of this study was to identify topical products used during pregnancy to prevent or reduce the development of striae gravidarum. We also explored issues around application of the product, cost incurred and influences on women’s decisions to use a product.

Methods

In this cross sectional, descriptive survey we collected data from 773 women, via a paper (n = 707) or online (n = 66) questionnaire. Due to missing data in the online survey, 753 women at 36 weeks gestation or more were included in the analyses. Descriptive and inferential statistical analyses were undertaken.

Results

Most respondents (n = 589, 78.2 %) indicated that they used a product to prevent or reduce the development of stretch marks during their current pregnancy. A large range of products were used and more than one third of women (n = 210, 36.5 %) had used two or more products. Bio-oil was the most frequently used product (n = 351, 60.9 %) and it was also the most frequently used product among women who used only one product (n = 189, 32.8 %).

Conclusions

Many women apply one of the many products available to prevent or reduce the development of striae gravidarum. Bio-oil was the most commonly used product identified in this study. There is a need for high-quality evidence on the effectiveness of Bio-oil and other products.
Literature
1.
go back to reference Muzaffar F, Hussain I, Haroon TS. Physiologic skin changes during pregnancy: a study of 140 cases. Int J Dermatol. 1998;37(6):429–31.CrossRefPubMed Muzaffar F, Hussain I, Haroon TS. Physiologic skin changes during pregnancy: a study of 140 cases. Int J Dermatol. 1998;37(6):429–31.CrossRefPubMed
2.
go back to reference Lawley TJ, Yancey KB. Skin changes and diseases in pregnancy. In: Freedberg IM, Eisen AZ, Wolf K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB, editors. Fitzpatrick's Dermatology in General Medicine, vol. II. 5th ed. New York: McGraw Hill; 1999. p. 1963–9. Lawley TJ, Yancey KB. Skin changes and diseases in pregnancy. In: Freedberg IM, Eisen AZ, Wolf K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB, editors. Fitzpatrick's Dermatology in General Medicine, vol. II. 5th ed. New York: McGraw Hill; 1999. p. 1963–9.
3.
go back to reference Buchanan K, Fletcher HM, Reid M. Prevention of striae gravidarum with cocoa butter cream. Int J Gynaecol Obstet. 2010;108(1):65–8.CrossRefPubMed Buchanan K, Fletcher HM, Reid M. Prevention of striae gravidarum with cocoa butter cream. Int J Gynaecol Obstet. 2010;108(1):65–8.CrossRefPubMed
5.
go back to reference Osman H, Rubeiz N, Tamim H, Nassar AH. Risk Factors for the development of striae gravidarum. Am J Obstet Gynecol. 2007;196(1):62.e1–e5.CrossRef Osman H, Rubeiz N, Tamim H, Nassar AH. Risk Factors for the development of striae gravidarum. Am J Obstet Gynecol. 2007;196(1):62.e1–e5.CrossRef
6.
go back to reference McKenzie AW. Skin disorders in pregnancy. Practitioner. 1971;206(236):773–80.PubMed McKenzie AW. Skin disorders in pregnancy. Practitioner. 1971;206(236):773–80.PubMed
7.
go back to reference Chang AL, Agredano YZ, Kimball AB. Risk factors associated with striae gravidarum. J Am Acad Dermatol. 2004;51(6):881–5.CrossRefPubMed Chang AL, Agredano YZ, Kimball AB. Risk factors associated with striae gravidarum. J Am Acad Dermatol. 2004;51(6):881–5.CrossRefPubMed
8.
go back to reference Elling SV, Powell FC. Physiological changes in the skin during pregnancy. Clin Dermatol. 1997;15(1):35–43.CrossRefPubMed Elling SV, Powell FC. Physiological changes in the skin during pregnancy. Clin Dermatol. 1997;15(1):35–43.CrossRefPubMed
10.
go back to reference Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY. Williams Obstetrics. 23rd ed. New York: McGraw Hill Medical; 2010. Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY. Williams Obstetrics. 23rd ed. New York: McGraw Hill Medical; 2010.
11.
go back to reference Kang S, Kim KJ, Griffith CEM, Wong TY, Talwar HS, Fisher GJ, et al. Topical tretinoin (retinoic acid) improves early stretch marks. Arch Dermatol. 1996;132(5):519–26.CrossRefPubMed Kang S, Kim KJ, Griffith CEM, Wong TY, Talwar HS, Fisher GJ, et al. Topical tretinoin (retinoic acid) improves early stretch marks. Arch Dermatol. 1996;132(5):519–26.CrossRefPubMed
13.
go back to reference Watson REB, Parry EJ, Humphries JD, Jones CJP, Polson DP, Kielty CM, et al. Fibrillin microfibrils are reduced in skin exhibiting striae distensae. Br J Dermatol. 1998;138(6):931–7.CrossRefPubMed Watson REB, Parry EJ, Humphries JD, Jones CJP, Polson DP, Kielty CM, et al. Fibrillin microfibrils are reduced in skin exhibiting striae distensae. Br J Dermatol. 1998;138(6):931–7.CrossRefPubMed
14.
go back to reference Murray I, Hassall J. Change and adaptation in pregnancy. In: Fraser DM, Cooper MA, editors. Myles Textbook for Midwives. 15th ed. Edinburgh: Churchill Livingstone Elsevier; 2009. p. 189–225. Murray I, Hassall J. Change and adaptation in pregnancy. In: Fraser DM, Cooper MA, editors. Myles Textbook for Midwives. 15th ed. Edinburgh: Churchill Livingstone Elsevier; 2009. p. 189–225.
15.
go back to reference Errickson CV, Matus NR. Skin disorders of pregnancy. Am Fam Physician. 1994;49(3):605–10.PubMed Errickson CV, Matus NR. Skin disorders of pregnancy. Am Fam Physician. 1994;49(3):605–10.PubMed
16.
go back to reference Ghasemi A, Gorouhi F, Rashighi-Firoozabadi M, Jafarian S, Firooz A. Striae Gravidarum: associated factors. J Eur Acad Dermatol Venereol. 2007;21(6):743–6.CrossRefPubMed Ghasemi A, Gorouhi F, Rashighi-Firoozabadi M, Jafarian S, Firooz A. Striae Gravidarum: associated factors. J Eur Acad Dermatol Venereol. 2007;21(6):743–6.CrossRefPubMed
17.
go back to reference Atwal GSS, Manku LK, Griffiths CEM, Polson DW. Striae gravidarum in primiparae. Br J Dermatol. 2006;55(5):965–9.CrossRef Atwal GSS, Manku LK, Griffiths CEM, Polson DW. Striae gravidarum in primiparae. Br J Dermatol. 2006;55(5):965–9.CrossRef
18.
go back to reference Martin AG, Leal-Khouri S. Physiologic skin changes associated with pregnancy. Int J Dermatol. 1992;31(6):375–8.CrossRefPubMed Martin AG, Leal-Khouri S. Physiologic skin changes associated with pregnancy. Int J Dermatol. 1992;31(6):375–8.CrossRefPubMed
19.
go back to reference Murray JC. Pregnancy and the skin. Dermatol Clin. 1990;8(2):327–34.PubMed Murray JC. Pregnancy and the skin. Dermatol Clin. 1990;8(2):327–34.PubMed
20.
go back to reference Shuster S. The cause of striae distensae. Acta Derm Venereol Suppl (Stockh). 1979;59(85):161–9. Shuster S. The cause of striae distensae. Acta Derm Venereol Suppl (Stockh). 1979;59(85):161–9.
21.
go back to reference Durmazlar SPK, Eskioglu F. Striae Gravidarum: associated factors in Primiparae. J Turk Acad Dermatol. 2009;3(4):93401a. Durmazlar SPK, Eskioglu F. Striae Gravidarum: associated factors in Primiparae. J Turk Acad Dermatol. 2009;3(4):93401a.
22.
go back to reference Bahrami N, Soleimani MA, Nia HS, Masodi R, Shaigan H, Afshar MH. Striae gravidarum in Iranian women: prevalence and associated factors. Life Sci J. 2012;9(4):3032–7. Bahrami N, Soleimani MA, Nia HS, Masodi R, Shaigan H, Afshar MH. Striae gravidarum in Iranian women: prevalence and associated factors. Life Sci J. 2012;9(4):3032–7.
23.
go back to reference Davey CM. Factors associated with the occurrence of striae gravidarum. J Obstet Gynaecol Br Commonw. 1972;79(12):1113–4.CrossRefPubMed Davey CM. Factors associated with the occurrence of striae gravidarum. J Obstet Gynaecol Br Commonw. 1972;79(12):1113–4.CrossRefPubMed
24.
go back to reference Murphy KW, Dunphy B, O'Herlihy C. Increased maternal age protects against striae gravidarum. Journal of Obstet Gynaecol. 1992;12(5):297–300.CrossRef Murphy KW, Dunphy B, O'Herlihy C. Increased maternal age protects against striae gravidarum. Journal of Obstet Gynaecol. 1992;12(5):297–300.CrossRef
25.
go back to reference Thomas RGR, Liston WA. Clinical associations of striae gravidarum. J Obstet Gynaecol. 2004;24(3):270–1.CrossRefPubMed Thomas RGR, Liston WA. Clinical associations of striae gravidarum. J Obstet Gynaecol. 2004;24(3):270–1.CrossRefPubMed
26.
go back to reference Lerdpienpitayakul R, Manusirivithaya S, Wiriyasirivaj B, Lorwatthanasirikul J. Prevalence and risk factors of striae gravidarum in Primiparae. Thai Journal of Obstetrics and Gynaecology. 2009;17:70–9. Lerdpienpitayakul R, Manusirivithaya S, Wiriyasirivaj B, Lorwatthanasirikul J. Prevalence and risk factors of striae gravidarum in Primiparae. Thai Journal of Obstetrics and Gynaecology. 2009;17:70–9.
27.
go back to reference Narin R, Nazik H, Narin MA, Nazik E, Özdemir F, Karabulutlu Ö, et al. Can different geographic conditions affect the formation of striae gravidarum? A multicentric study. J Obstet Gynaecol Res. 2015;41(9):1377–83.CrossRefPubMed Narin R, Nazik H, Narin MA, Nazik E, Özdemir F, Karabulutlu Ö, et al. Can different geographic conditions affect the formation of striae gravidarum? A multicentric study. J Obstet Gynaecol Res. 2015;41(9):1377–83.CrossRefPubMed
28.
go back to reference Kasielska-Trojan A, Sobczak M, Antoszewski B. Risk factors of striae gravidarum. Int J Cosmet Sci. 2015;37(2):236–40.CrossRefPubMed Kasielska-Trojan A, Sobczak M, Antoszewski B. Risk factors of striae gravidarum. Int J Cosmet Sci. 2015;37(2):236–40.CrossRefPubMed
29.
30.
go back to reference Rangel O, Arias I, Garcia E, Lopez-Padilla S. Topical Tretinoin 0.1 % for pregnancy-related abdominal striae: an open-label, multicenter, prospective study. Adv Ther. 2001;18(4):181–6.CrossRefPubMed Rangel O, Arias I, Garcia E, Lopez-Padilla S. Topical Tretinoin 0.1 % for pregnancy-related abdominal striae: an open-label, multicenter, prospective study. Adv Ther. 2001;18(4):181–6.CrossRefPubMed
31.
go back to reference Muallem MM, Rubeiz NG. Physiological and biological skin changes in pregnancy. Clin Dermatol. 2006;24(2):80–3.CrossRefPubMed Muallem MM, Rubeiz NG. Physiological and biological skin changes in pregnancy. Clin Dermatol. 2006;24(2):80–3.CrossRefPubMed
32.
go back to reference Yamaguchi K, Suganuma N, Ohashi K. Quality of life evaluation in Japanese pregnant women with striae gravidarum: a cross-sectional study. BMC Res Notes. 2012;5:450. doi:10.1186/1756-0500-5-450. Yamaguchi K, Suganuma N, Ohashi K. Quality of life evaluation in Japanese pregnant women with striae gravidarum: a cross-sectional study. BMC Res Notes. 2012;5:450. doi:10.​1186/​1756-0500-5-450.
33.
go back to reference Elsaie ML, Baumann LS, Elsaaiee LT. Striae distensae (stretch marks) and different modalities of therapy: an update. Dermatol Surg. 2009;35(4):563–73.CrossRefPubMed Elsaie ML, Baumann LS, Elsaaiee LT. Striae distensae (stretch marks) and different modalities of therapy: an update. Dermatol Surg. 2009;35(4):563–73.CrossRefPubMed
34.
go back to reference Summers B, Lategan M. The effect of a topically-applied cosmetic oil formulation on striae distensae. SA Fam Practitioner. 2009;51(4):332–6. Summers B, Lategan M. The effect of a topically-applied cosmetic oil formulation on striae distensae. SA Fam Practitioner. 2009;51(4):332–6.
35.
go back to reference García Hernández JÁ, Madera González D, Padilla Castillo M, Figueras Falcón T. Use of a specific anti-stretch mark cream for preventing or reducing the severity of striae gravidarum. Randomized, double-blind, controlled trial. Int J Cosmet Sci. 2013;35(3):233–7.CrossRefPubMed García Hernández JÁ, Madera González D, Padilla Castillo M, Figueras Falcón T. Use of a specific anti-stretch mark cream for preventing or reducing the severity of striae gravidarum. Randomized, double-blind, controlled trial. Int J Cosmet Sci. 2013;35(3):233–7.CrossRefPubMed
36.
go back to reference Brennan M, Young G, Devane D. Topical preparations for preventing stretch marks in pregnancy. Cochrane Database Syst Rev (Online). 2012;11:CD000066. Brennan M, Young G, Devane D. Topical preparations for preventing stretch marks in pregnancy. Cochrane Database Syst Rev (Online). 2012;11:CD000066.
38.
go back to reference Kelley K, Clark B, Brown V, Sitzia J. Good practice in the conduct and reporting of survey research. Int J Qual Health Care. 2003;15(3):261–6.CrossRefPubMed Kelley K, Clark B, Brown V, Sitzia J. Good practice in the conduct and reporting of survey research. Int J Qual Health Care. 2003;15(3):261–6.CrossRefPubMed
39.
go back to reference Burns KEA, Duffett M, Kho ME, Meade MO, Adhikari NKJ, Sinuff T, et al. A guide for the design and conduct of self-administered surveys of clinicians. CMAG. 2008;179(3):245–52. Burns KEA, Duffett M, Kho ME, Meade MO, Adhikari NKJ, Sinuff T, et al. A guide for the design and conduct of self-administered surveys of clinicians. CMAG. 2008;179(3):245–52.
40.
go back to reference De Vaus D. Surveys in Social Research. London: Routledge; 2002. De Vaus D. Surveys in Social Research. London: Routledge; 2002.
41.
go back to reference Oppenheim AN. Questionnaire Design, Interviewing and Attitude Measurement, New ed. London: Pinter Publishers; 1992. Oppenheim AN. Questionnaire Design, Interviewing and Attitude Measurement, New ed. London: Pinter Publishers; 1992.
42.
43.
go back to reference Polit DF, Beck CT, Owen SV. Is the CVI an acceptable indicator of content validity? Appraisal and recommendations. Res Nurs Health. 2007;30(4):459–67.CrossRefPubMed Polit DF, Beck CT, Owen SV. Is the CVI an acceptable indicator of content validity? Appraisal and recommendations. Res Nurs Health. 2007;30(4):459–67.CrossRefPubMed
44.
45.
go back to reference Collins D. Pretesting survey instruments: an overview of cognitive methods. Qual Life Res. 2003;12(3):229.CrossRefPubMed Collins D. Pretesting survey instruments: an overview of cognitive methods. Qual Life Res. 2003;12(3):229.CrossRefPubMed
46.
go back to reference Corp. I. SPSS. 210th ed. Armonk: IBM Corp; 2012. Corp. I. SPSS. 210th ed. Armonk: IBM Corp; 2012.
47.
go back to reference Yamaguchi K, Suganuma N, Ohashi K. Prevention of striae gravidarum and quality of life among pregnant Japanese women. Midwifery. 2014;30(6):595–9.CrossRefPubMed Yamaguchi K, Suganuma N, Ohashi K. Prevention of striae gravidarum and quality of life among pregnant Japanese women. Midwifery. 2014;30(6):595–9.CrossRefPubMed
49.
go back to reference Osman H, Usta IM, Rubeiz N, Abu-Rustum R, Charara I, Nassar AH. Cocoa butter lotion for prevention of striae gravidarum: a double-blind, randomised and placebo-controlled trial. BJOG. 2008;115(9):1138–42.CrossRefPubMed Osman H, Usta IM, Rubeiz N, Abu-Rustum R, Charara I, Nassar AH. Cocoa butter lotion for prevention of striae gravidarum: a double-blind, randomised and placebo-controlled trial. BJOG. 2008;115(9):1138–42.CrossRefPubMed
50.
go back to reference Poidevin LOS. Striae gravidarum. Their relation to adrenal cortical hyperfunction. Lancet. 1959;2(7100):436–9.CrossRefPubMed Poidevin LOS. Striae gravidarum. Their relation to adrenal cortical hyperfunction. Lancet. 1959;2(7100):436–9.CrossRefPubMed
51.
go back to reference Taavoni S, Soltanipour F, Haghani H, Ansarian H, Kheirkhah M. Effects of olive oil on striae gravidarum in the second trimester of pregnancy. Complement Ther Clin Pract. 2011;17(3):167–70.CrossRefPubMed Taavoni S, Soltanipour F, Haghani H, Ansarian H, Kheirkhah M. Effects of olive oil on striae gravidarum in the second trimester of pregnancy. Complement Ther Clin Pract. 2011;17(3):167–70.CrossRefPubMed
52.
go back to reference Soltanipoor F, Delaram M, Taavoni S, Haghani H. The effect of olive oil on prevention of striae gravidarum: a randomized controlled clinical trial. Complement Ther Med. 2012;20(5):263–6.CrossRefPubMed Soltanipoor F, Delaram M, Taavoni S, Haghani H. The effect of olive oil on prevention of striae gravidarum: a randomized controlled clinical trial. Complement Ther Med. 2012;20(5):263–6.CrossRefPubMed
53.
go back to reference Timur Taşhan S, Kafkasli A. The effect of bitter almond oil and massaging on striae gravidarum in primiparaous women. J Clin Nurs. 2012;21(11–12):1570–6.CrossRefPubMed Timur Taşhan S, Kafkasli A. The effect of bitter almond oil and massaging on striae gravidarum in primiparaous women. J Clin Nurs. 2012;21(11–12):1570–6.CrossRefPubMed
54.
go back to reference Grimes HA, Forster DA, Newton MS. Sources of information used by women during pregnancy to meet their information needs. Midwifery. 2014;30(1):e26–33.CrossRefPubMed Grimes HA, Forster DA, Newton MS. Sources of information used by women during pregnancy to meet their information needs. Midwifery. 2014;30(1):e26–33.CrossRefPubMed
55.
go back to reference Lagan BM, Sinclair M, Kernohan WG. What is the impact of the internet on decision-making in pregnancy? A global study. Birth. 2011;38(4):336–45.CrossRefPubMed Lagan BM, Sinclair M, Kernohan WG. What is the impact of the internet on decision-making in pregnancy? A global study. Birth. 2011;38(4):336–45.CrossRefPubMed
56.
go back to reference Lagan BM, Sinclair M, George Kernohan W. Internet use in pregnancy informs women's decision making: a web-based survey. Birth. 2010;37(2):106–15.CrossRefPubMed Lagan BM, Sinclair M, George Kernohan W. Internet use in pregnancy informs women's decision making: a web-based survey. Birth. 2010;37(2):106–15.CrossRefPubMed
57.
go back to reference Larsson M. A descriptive study of the use of the internet by women seeking pregnancy-related information. Midwifery. 2009;25(1):14–20.CrossRefPubMed Larsson M. A descriptive study of the use of the internet by women seeking pregnancy-related information. Midwifery. 2009;25(1):14–20.CrossRefPubMed
58.
go back to reference Mallol J, Belda MA, Costa D, Noval A, Sola M. Prophylaxis of striae gravidarum with a topical formulation. A double blind trial. Int J Cosmet Sci. 1991;3:51–7.CrossRef Mallol J, Belda MA, Costa D, Noval A, Sola M. Prophylaxis of striae gravidarum with a topical formulation. A double blind trial. Int J Cosmet Sci. 1991;3:51–7.CrossRef
59.
go back to reference Treweek S, Pitkethly M, Cook J, Kjeldstrom M, Taskila T, Johansen M, et al. Strategies to improve recruitment to randomised controlled trials. Cochrane Database Syst Rev (Online). 2010;4:MR000013. Treweek S, Pitkethly M, Cook J, Kjeldstrom M, Taskila T, Johansen M, et al. Strategies to improve recruitment to randomised controlled trials. Cochrane Database Syst Rev (Online). 2010;4:MR000013.
60.
go back to reference Saolta. Women's and Children's Directorate Annual Clinical Report 2014. Galway: Saolta Health Care Group; 2015. Saolta. Women's and Children's Directorate Annual Clinical Report 2014. Galway: Saolta Health Care Group; 2015.
62.
go back to reference Bowling A. Research Methods in Health. 3rd ed. England: McGraw Hill Open University Press; 2009. Bowling A. Research Methods in Health. 3rd ed. England: McGraw Hill Open University Press; 2009.
Metadata
Title
The use of anti stretch marks’ products by women in pregnancy: a descriptive, cross-sectional survey
Authors
Miriam Brennan
Mike Clarke
Declan Devane
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Pregnancy and Childbirth / Issue 1/2016
Electronic ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-016-1075-9

Other articles of this Issue 1/2016

BMC Pregnancy and Childbirth 1/2016 Go to the issue